Proteomics International Confirms US Reimbursement Price for ProMarkerD Diabetic Kidney Disease Test
Proteomics International Laboratories (ASX: PIQ) has announced that the US Centres for Medicare & Medicaid Services (CMS) has set a...
Disease
The Evolving Landscape of Liver Disease: Innovation, Integration, and Impact
Why Liver Disease? A Vision for Change Liver disease has emerged as a critical focus for the healthcare science community,...
Key to Kidney Disease Management
In an era where healthcare systems are continually evolving, a recent study underscores the pivotal role of health literacy, particularly...
Global Liver Disease Therapeutic Market Trends & Summary
The global liver disease therapeutic market is on a strong upward path, driven by growing disease prevalence, rapid medical innovation,...
Real-world burden of primary hyperoxaluria with chronic kidney disease in the United States: a retrospective administrative claims analysis | BMC Nephrology
Disease epidemiology and characterization of PHBased on claims with a PH diagnosis in the CMS Medicare FFS LDS and MarketScan...
Chronic kidney disease in India 138 million affected rising prevalence poor diabetes control
When a disease grows silently, it’s easy to miss until it’s too late. That’s precisely what’s happening in India with...
